Janet Dorling

2019

In 2019, Janet Dorling earned a total compensation of $2M as Former Chief Commercial Officer at Cymabay Therapeutics.

Compensation breakdown

Bonus$15,000
Option Awards$1,303,336
Salary$163,846
Other$558,870
Total$2,041,052

Dorling received $1.3M in option awards, accounting for 64% of the total pay in 2019.

Dorling also received $15K in bonus, $163.8K in salary and $558.9K in other compensation.

Rankings

In 2019, Janet Dorling's compensation ranked 5,826th out of 13,971 executives tracked by ExecPay. In other words, Dorling earned more than 58.3% of executives.

ClassificationRankingPercentile
All
5,826
out of 13,971
58th
Division
Manufacturing
2,182
out of 5,695
62nd
Major group
Chemicals And Allied Products
786
out of 2,194
64th
Industry group
Drugs
662
out of 1,880
65th
Industry
Pharmaceutical Preparations
487
out of 1,392
65th
Source: SEC filing on May 15, 2020.

Dorling's colleagues

We found four more compensation records of executives who worked with Janet Dorling at Cymabay Therapeutics in 2019.

2019

Sujal Shah

Cymabay Therapeutics

Chief Executive Officer

2019

Pol Boudes

Cymabay Therapeutics

Chief Medical Officer

2019

Charles McWherter

Cymabay Therapeutics

Chief Scientific Officer

2019

Klara Dickinson

Cymabay Therapeutics

Chief Regulatory and Compliance Officer

News

In-depth

You may also like